Riten Kumar, Director, Thrombosis and Anticoagulation Program at Boston Children’s Hospital, shared on LinkedIn:
“Direct oral anticoagulants are efficacious when appropriately used in children with cancer associated thrombosis – though the rate of clinically relevant bleeding in this cohort was higher than what’s been reported in the pediatric randomized trials.
Most CRNM bleeds occurred in the setting of thrombocytopenia.”
Title: Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers
Authors: Oliver Kepp, Xiaolian Deng, Enfu Xue, Baldur Sveinbjørnsson, Øystein Rekdal, Lorenzo Galluzzi, Guido Kroemer
Read the Full Article.
Other articles featuring Pediatric Oncology.